Mini-Reviews in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 19 Issue: 19
Author(s): Claudio Viegas
Affiliation:
Export Options
About this article
Cite this article as:
Viegas Claudio, Meet Our Editorial Board Member, Mini-Reviews in Medicinal Chemistry 2019; 19 (19) . https://dx.doi.org/10.2174/138955751919191024105752
DOI https://dx.doi.org/10.2174/138955751919191024105752 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Novel Prescription for Alzheimer’s Disease: Targeting Hypercoagulable States
Current Neurovascular Research Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs
Current Medicinal Chemistry The Added Value of Liquid Antipsychotics: The Case of Quetiapine
Current Clinical Pharmacology Morphine as a Potential Oxidative Stress-Causing Agent
Mini-Reviews in Organic Chemistry The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
Current Topics in Medicinal Chemistry Voltammetric Method for Simultaneous Determination of L-Dopa and Benserazide
Current Analytical Chemistry Determination of the Frequency and Direct Cost of the Adverse Drug Events in Argentina
Current Drug Safety FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT)
Current Alzheimer Research Wnt1 Inducible Signaling Pathway Protein 1 (WISP1) Targets PRAS40 to Govern β-Amyloid Apoptotic Injury of Microglia
Current Neurovascular Research Cystatin C in Cerebrovascular Disorders
Current Neurovascular Research Catechol-O-Methyltransferase and Alzheimer's Disease: A Review of Biological and Genetic Findings
CNS & Neurological Disorders - Drug Targets Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells
Current Signal Transduction Therapy Insulin-Degrading Enzyme: A Link Between Alzheimer’s and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Judging Children as Children
Adolescent Psychiatry Molecular Methods for Individualization of Psychotropic Drug Treatment
Current Pharmacogenomics Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists
Recent Patents on CNS Drug Discovery (Discontinued) Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
Current Neuropharmacology Alzheimers Disease - An Interactive Perspective
Current Alzheimer Research Ceramide-Based Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry FKBP Ligands as Novel Therapeutics for Neurological Disorders
Mini-Reviews in Medicinal Chemistry